您要查找的是不是：
- urokinase pasminogenactivator 尿激酶型纤溶酶原激活剂
- The method and technology of urokinase are studied here. 该文对尿激酶纯化方法与技术进行了研究。
- All cases received heparin and urokinase perioperatively. 围手术期抗凝治疗。
- Impact Thrombolytic Therapy of Acute Cerebral Infarction with Urokinase. 尿激酶冲击溶栓治疗急性脑梗塞。
- Thrombolytic therapy of acute MVT with Urokinase and Batroxobin is feasible,effective and safe. 尿激酶联合巴曲酶治疗MVT是有效和安全的。
- Methods All 82 patients received intravenous urokinase (UK) for acute ischemic stroke. 方法 82例急性脑梗死患者接受尿激酶 (UK)静脉溶栓治疗。
- Treament of acute ischemic cerebral vascular disease with urokinase intravenous dissolving blood-cork. 尿激酶静脉溶栓治疗急性缺血性脑血管病31例临床分析
- Objective:In order to study the effect of urokinase to myocardial infarction spectrum(MIS). 目的:为观察尿激酶对心肌梗塞范围(MIS)的影响;
- Objective: To observe the effects of intrapleural urokinase in the treatment of the tuberculous pleural effusion. 目的:观察胸膜腔内注入尿激酶治疗结核性胸膜炎的效果。
- Results:Thrombolysis therapy of urokinase can significantly decrease MIS,saving ischemic myocardium. 结果:用尿激酶溶栓治疗可显著减少(MIS),挽救缺血濒死的心肌;
- Patients who presented within 3 to 6 hours of symptom onset received intra-arterial urokinase. 起病3至6小时之间的患者直接进行血管内溶栓治疗。
- Early experience in fibrinolysis for acute PE utilized the first generation agents， streptokinase and urokinase. 最早用于急性PE纤溶治疗的是第一代纤溶药物，即链激酶和尿激酶。
- Methods: Fifteen cases of deep vein thrombosis were treated with urokinase, low molecular weight heparin anticoagulate. 方法:用尿激酶溶栓,低分子量肝素抗凝,低分子右旋糖酐祛聚疗法,治疗下肢深静脉血栓15例。
- Methods: Ninety patients with AMI were treated by intravenous infusion of urokinase in CCU. 方法:在冠心病监护病房行静脉溶栓治疗。
- Expression of p-selectin in renal tissue was down regulated after using of either urokinase or papaverine. 5. 4.;通过免疫组织化学染色，观察到了罂粟碱或尿激酶应用后，缺血再灌注损伤大鼠肾脏组织内p-selectin表达的下调。
- CONCLUSION:It is effective and safety for thrombolytic therapy with Urokinase in unstable angina pectoris. 结论:在积极抗血小板、抗凝治疗下,对不稳定型心绞痛溶栓是安全有效的。并不增加患者死亡率。
- AIM：To observe the clinical efficacy and safety using Urokinase (UK) in unstable angina pectoris(UAP). 目的：观察尿激酶在治疗不稳定型心绞痛(UAP)中的疗效和安全性。
- Objective:To explore the possibility of the simultaneous extraction of urokinase and kallikrein. 目的:探讨尿激酶及激肽释放酶同时提取的可能性。
- Objective:To study the effect of intrapleural injection of urokinase on the curative effect of tuberculous pleuritis. 目的:观察胸膜腔内注入尿激酶对结核性胸膜炎疗效的影响。
